Apotex president, CEO Jeremy Desai resigns amid allegations of trade secret leaks | The Star
Apotex Inc. president and CEO Jeremy Desai resigned from the generic drug giant Friday while facing a lawsuit alleging he and the company accepted trade secrets leaked from a competitor. The lawsuit from Teva Pharmaceutical Industries Ltd. accuses Barinder Sandhu, who worked as a senior director of regulatory affairs for Teva’s U.S.
Name: Jeremy Desai
Continent: North America
Country: Canada
Company: Apotex
Branch: Pharma
Position: CEO
Reason: Resigned
Announcement Date: January 25, 2018, 11:00pm
Resignation Date: January 25, 2018, 11:00pm
Source 1: https://www.thestar.com/news/gta/2018/01/26/apotex-president-and-ceo-jeremy-desai-resigns.html